Join us for a career panel discussion with four UM alumni from different large corporations including Genetech, AstraZeneca and 23andMe. They will share their past and current experiences, especially how they landed on the current position during COVID19 pandemic.
Read about the panelists:
- Dr. Paloma Garcia defended her PhD in Molecular and Cellular Pathology in March 2020. During graduate school, she studied the origins of pancreatic tumor stroma in Dr. Pasca di Magliano's lab, served as President at miLEAD Consulting, and participated in an Genentech internship. Now she works as a Research Associate in the Cancer Immunology department of Genentech studying immunosuppressive pathways in liver cancer.
- Dr. Amy Yu was an Immunology PhD graduate student in Grace Chen’s lab. She studied immune-microbiome interactions in colorectal cancer and virtually defended her thesis in April 2020. In September 2020, she started an Associate Scientist job in the Therapeutics Department at 23andMe where she helps validate potential drug targets in autoimmune diseases.
- Dr. Xu Liu got his Ph.D. degree in Molecular, Cellular, and Developmental Biology at UM in April 2017. After graduation, he stayed in, his PhD mentor, Dr. Daniel Klionsky's lab for about another two years as a postdoctoral research fellow. At UM he studied the molecular mechanisms of autophagy and how autophagy activity is regulated under different stress conditions. In March 2019, he joined Dr. Matthew Waldor's lab at the Harvard Medical School, investigating the roles of autophagy in host-pathogen interaction at the gastrointestinal tract. In September 2020, he started to work for AstraZeneca as a Senior Scientist, where he supports the oncology pipeline by assessing and predicting drug induced gastrointestinal (GI) toxicity.
- Dr. Racquel Domingo-Gonzalez is a Principal Scientific Researcher in the Department of Infectious Diseases at Genentech. She received her Bachelor of Science in Microbiology from the University of California, Santa Barbara and later completed her PhD in Immunology at U of M under the mentorship of Dr. Bethany Moore. Her PhD studies aimed to understand how the lung immune response is altered following stem cell transplantation. Prior to joining Genentech she held two postdoctoral positions, the first at Washington University in St. Louis, investigating early innate immune responses to tuberculosis, and the second at Stanford University, where she generated an immune atlas of the murine lung during a time of rapid post-natal growth and development using single cell technology.
